Similar articles

• Assessment and management of high-risk pregnancies in women with thrombophilia.

  Sarig G, Vidergor G, Brenner B. Sarig G, et al. Blood Rev. 2009 Jul;23(4):143-7. doi: 10.1016/j.blre.2008.11.001. Epub 2009 Jan 8. Blood Rev. 2009. PMID: 19135285 Review.
• Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism in at-risk pregnant women: a review.

  Duhl AJ. Duhl AJ. J Reprod Med. 2008 Sep;53(9):657-66. J Reprod Med. 2008. PMID: 18839817
• Management of thromboembolism in pregnancy.

  Marks PW. Marks PW. Semin Perinatol. 2007 Aug;31(4):227-31. doi: 10.1053/j.semperi.2007.07.010. Semin Perinatol. 2007. PMID: 17825678
• Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.

  James AH, Brancazio LR, Ortel TL. James AH, et al. Clin Adv Hematol Oncol. 2005 Mar;3(3):187-97. Clin Adv Hematol Oncol. 2005. PMID: 16166990 Review.
• Low molecular weight heparin as thromboprophylaxis in familial thrombophilia during the whole period of pregnancy.

  Boda Z, Laszlo P, Rejtõ L, Tornai I, Pfliegler G, Blaskó G, Rak K. Boda Z, et al. Thromb Haemost. 1996 Jul;76(1):128. Thromb Haemost. 1996. PMID: 8819268 No abstract available.